Toshiba releases cardiac 4D ultrasound
CHICAGO—Toshiba America Medical Systems entered the 4D echocardiography market this week with the release of its new Aplio Artida ultrasound system at the American College of Cardiology (ACC) Scientific Sessions.
The Artida meets the demands of the growing cardiac 4D market, Toshiba said. With Artida’s real-time, multi-planar reformatting capabilities, physicians can quantify global and regional LV function, including LV ejection fraction, volume and severity of regurgitation, according to the company. Arbitrary views of the heart not available in 2D imaging are also obtained that can help with surgical planning.
Toshiba said Artida is the first ultrasound system with the ability to track myocardial motion and display myocardial motion in 3D images.
The Artida meets the demands of the growing cardiac 4D market, Toshiba said. With Artida’s real-time, multi-planar reformatting capabilities, physicians can quantify global and regional LV function, including LV ejection fraction, volume and severity of regurgitation, according to the company. Arbitrary views of the heart not available in 2D imaging are also obtained that can help with surgical planning.
Toshiba said Artida is the first ultrasound system with the ability to track myocardial motion and display myocardial motion in 3D images.